Publicaciones en las que colabora con Juan Fernando García García (22)

2023

  1. NanoString analysis of mycosis fungoides reveals individual molecular identity

    British Journal of Dermatology

2018

  1. Molecular study of long-term survivors of glioblastoma by gene-targeted next-generation sequencing

    Journal of Neuropathology and Experimental Neurology, Vol. 77, Núm. 8, pp. 710-716

2017

  1. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

    Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395

2015

  1. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients

    Journal of Neuro-Oncology, Vol. 122, Núm. 3, pp. 441-450

2014

  1. Evaluación sistemática de la biopsia de médula ósea en casos de sospecha de mielofibrosis primaria. Propuesta de informe diagnóstico estandarizado. Consenso de expertos de las SEAP/SEHH

    Revista Espanola de Patologia

  2. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  3. Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report

    Journal of Clinical Pathology, Vol. 67, Núm. 7, pp. 620-625

  4. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors

    Acta Neuropathologica, Vol. 126, Núm. 2, pp. 277-289

  2. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas

    Blood Cancer Journal, Vol. 3, Núm. 4

  3. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

  4. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

2010

  1. Aggressive large B-cell lymphoma with plasma cell differentiation: Immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

    Haematologica, Vol. 95, Núm. 8, pp. 1342-1349

  2. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

  3. Intrafollicular neoplasia/in situ follicular lymphoma: Review of a series of 13 cases

    Histopathology

2009

  1. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers

    American Journal of Surgical Pathology, Vol. 33, Núm. 1, pp. 81-90

2006

  1. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

    Blood, Vol. 108, Núm. 2, pp. 662-668

2005

  1. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

    Leukemia, Vol. 19, Núm. 12, pp. 2247-2253

2004

  1. Posible implicación de las alteraciones moleculares de la vía de TNF en la tumorigénesis de la micosis fungoide. Descripción de un posible chip de diagnóstico molecular en micosis fungoide

    Actas Dermo-Sifiliograficas, Vol. 95, Núm. 2, pp. 86-96

  2. Variability in the degree of expression of phosphorylated IκBα chronic lymphocytic leukemia cases with nodal involvement

    Clinical Cancer Research, Vol. 10, Núm. 20, pp. 6796-6806